Medical marijuana is associated with significant improvements in life enjoyment, general activity and physical wellbeing among Minnesota chronic pain patients, according to a new study from researchers at the state’s Office of Cannabis Management (OCM).
The peer-reviewed study, published in the journal Clinical Therapeutics, analyzed data from more than 6,000 chronic pain patients in Minnesota’s medical marijuana program from March 2022 to February 2023. It represents a more narrowly tailored review of medical cannabis patient outcomes that OCM published in a broader report last year.
Researchers at OCM’s Division of Data and Analytics specifically looked at chronic pain patients who reported participating in the cannabis program for at least eight months, assessing the impact of medical marijuana use based on their on pain, enjoyment of life and general activity, or PEG, score.
The latest study iteration also features novel data on product preferences among the pain patient cohort.
“Medical cannabis patients report improvement in pain symptoms after four months.”
“Patients in the Minnesota Medical Cannabis Program report decreased interference to life enjoyment and general activity from pain symptoms 4 months after starting medical cannabis,” the study found.
Specifically, among pain patients with moderate-to-severe PEG scores at the time of enrolling
Read full article on Marijuana Moment
